Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.76 | N/A |
PEG Ratio (TTM) | -0.06 | N/A |
P/S Ratio (TTM) | 2.83 | N/A |
P/B Ratio (TTM) | 0.63 | N/A |
P/FCF Ratio (TTM) | -145.63 | N/A |
Price to 5YR AVG Earnings Ratio | 0.00 | N/A |
Price to 5YR AVG FCF Ratio | -0.09 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -10.81% | N/A |
ROE (TTM) | -13.58% | N/A |
Net Profit Margin (TTM) | -31.93% | N/A |
ROIC 5YR AVG | -356.74% | N/A |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -16.94% | -169.65% | -100.47% |
Revenue | 44.62% | -18.37% | -46.56% |
Net Income | 4.61% | -188.01% | -111.11% |
Cash Flow | 454.02% | -550.80% | -299.45% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.14 | N/A |
Quick Ratio (TTM) | 2.16 | N/A |
D/E Ratio (TTM) | 0.03 | N/A |
Interest Coverage (TTM) | -154.05 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | 179.02% | N/A |